ID   RPGF2_RAT               Reviewed;        1496 AA.
AC   F1M386; D3ZD17;
DT   14-DEC-2011, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 2.
DT   02-OCT-2024, entry version 85.
DE   RecName: Full=Rap guanine nucleotide exchange factor 2;
DE   AltName: Full=Cyclic nucleotide ras GEF;
DE            Short=CNrasGEF;
DE   AltName: Full=Neural RAP guanine nucleotide exchange protein;
DE            Short=nRap GEP;
DE   AltName: Full=PDZ domain-containing guanine nucleotide exchange factor 1;
DE            Short=PDZ-GEF1;
DE   AltName: Full=RA-GEF-1;
DE   AltName: Full=Ras/Rap1-associating GEF-1;
GN   Name=Rapgef2; Synonyms=Pdzgef1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH MAGI2, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10548487; DOI=10.1006/bbrc.1999.1619;
RA   Ohtsuka T., Hata Y., Ide N., Yasuda T., Inoue E., Inoue T., Mizoguchi A.,
RA   Takai Y.;
RT   "nRap GEP: a novel neural GDP/GTP exchange protein for rap1 small G protein
RT   that interacts with synaptic scaffolding molecule (S-SCAM).";
RL   Biochem. Biophys. Res. Commun. 265:38-44(1999).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10873669; DOI=10.1006/bbrc.2000.3002;
RA   Kawajiri A., Itoh N., Fukata M., Nakagawa M., Yamaga M., Iwamatsu A.,
RA   Kaibuchi K.;
RT   "Identification of a novel beta-catenin-interacting protein.";
RL   Biochem. Biophys. Res. Commun. 273:712-717(2000).
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=10801446; DOI=10.1016/s0960-9822(00)00473-5;
RA   Pham N., Cheglakov I., Koch C.A., de Hoog C.L., Moran M.F., Rotin D.;
RT   "The guanine nucleotide exchange factor CNrasGEF activates ras in response
RT   to cAMP and cGMP.";
RL   Curr. Biol. 10:555-558(2000).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12391161; DOI=10.1128/mcb.22.22.7942-7952.2002;
RA   Pak Y., Pham N., Rotin D.;
RT   "Direct binding of the beta1 adrenergic receptor to the cyclic AMP-
RT   dependent guanine nucleotide exchange factor CNrasGEF leads to Ras
RT   activation.";
RL   Mol. Cell. Biol. 22:7942-7952(2002).
RN   [7]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH KIDINS220; MAGI2 AND NTRK1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17724123; DOI=10.1083/jcb.200610073;
RA   Hisata S., Sakisaka T., Baba T., Yamada T., Aoki K., Matsuda M., Takai Y.;
RT   "Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes,
RT   leading to sustained activation of Rap1 and ERK and neurite outgrowth.";
RL   J. Cell Biol. 178:843-860(2007).
RN   [8]
RP   PHOSPHORYLATION AT THR-644; SER-806; SER-933; SER-1022 AND SER-1175, AND
RP   MUTAGENESIS OF THR-644; SER-806; SER-933; SER-1022 AND SER-1175.
RX   PubMed=21382555; DOI=10.1016/j.neuron.2011.02.004;
RA   Lee K.J., Lee Y., Rozeboom A., Lee J.Y., Udagawa N., Hoe H.S., Pak D.T.;
RT   "Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic
RT   structural plasticity, and memory.";
RL   Neuron 69:957-973(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-501; SER-930 AND SER-1115,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Functions as a guanine nucleotide exchange factor (GEF),
CC       which activates Rap and Ras family of small GTPases by exchanging bound
CC       GDP for free GTP in a cAMP-dependent manner. Serves as a link between
CC       cell surface receptors and Rap/Ras GTPases in intracellular signaling
CC       cascades. Acts also as an effector for Rap1 by direct association with
CC       Rap1-GTP thereby leading to the amplification of Rap1-mediated
CC       signaling. Shows weak activity on HRAS. It is controversial whether
CC       RAPGEF2 binds cAMP and cGMP or not. Its binding to ligand-activated
CC       beta-1 adrenergic receptor ADRB1 leads to the Ras activation through
CC       the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and
CC       Erk1/2 signaling pathway that leads to sustained inhibition of long
CC       term melanogenesis by reducing dendrite extension and melanin
CC       synthesis. Provides also inhibitory signals for cell proliferation of
CC       melanoma cells and promotes their apoptosis in a cAMP-independent
CC       nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-
CC       Raf/ERK signaling through a pathway that is independent on both PKA and
CC       RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of
CC       the major forebrain fiber connections forming the corpus callosum, the
CC       anterior commissure and the hippocampal commissure during brain
CC       development. Involved in neuronal growth factor (NGF)-induced sustained
CC       activation of Rap1 at late endosomes and in brain-derived neurotrophic
CC       factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a
CC       role in the regulation of embryonic blood vessel formation and in the
CC       establishment of basal junction integrity and endothelial barrier
CC       function. May be involved in the regulation of the vascular endothelial
CC       growth factor receptor KDR and cadherin CDH5 expression at allantois
CC       endothelial cell-cell junctions. {ECO:0000269|PubMed:17724123}.
CC   -!- SUBUNIT: Interacts (via C-terminal domain) with NEDD4 (via WW domains);
CC       this interaction leads to ubiquitination and degradation via the
CC       proteasome pathway in a cAMP-independent manner. Interacts with MAGI1
CC       (via PDZ domain). Interacts with ADRB1 (via C-terminal PDZ motif); the
CC       interaction is direct. Interacts (via Ras-associating domain) with
CC       RAP1A (via GTP-bound active form). Interacts weakly with HRAS (via
CC       GDP- and GTP-bound forms). Interacts (via C-terminal domain) with MAGI2
CC       (via PDZ and WW domains). Interacts with CDH1, CTNNB1 and TJP1 (By
CC       similarity). Found in a complex, at least composed of KIDINS220, MAGI2,
CC       NTRK1 and RAPGEF2; the complex is mainly formed at late endosomes in a
CC       neuronal growth factor (NGF)-dependent manner. Interacts (via C-
CC       terminal domain) with MAGI2 (via PDZ and WW domains); the interaction
CC       occurs before or after NGF stimulation. Interacts with KIDINS220 and
CC       NTRK1; the interactions occur after NGF stimulation. {ECO:0000250,
CC       ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:17724123}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10548487,
CC       ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:12391161,
CC       ECO:0000269|PubMed:17724123}. Cytoplasm {ECO:0000250}. Cytoplasm,
CC       perinuclear region {ECO:0000250}. Late endosome {ECO:0000250}. Cell
CC       junction {ECO:0000250}. Note=Associated with the synaptic plasma
CC       membrane. Localized diffusely in the cytoplasm before neuronal growth
CC       factor (NGF) stimulation. Recruited to late endosomes after NGF
CC       stimulation. Colocalized with the high affinity nerve growth factor
CC       receptor NTRK1 at late endosomes. Translocated to the perinuclear
CC       region in a RAP1A-dependent manner. Translocated to the cell membrane.
CC       Colocalized with CTNNB1 at cell-cell contacts (By similarity).
CC       Colocalizes with ADRB1 at the plasma membrane. Synaptosome. Enriched in
CC       synaptic plasma membrane and neuronal cell body. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, heart, lung, liver and
CC       stomach. Expressed in the granular layer of the cerebellum. Expressed
CC       in Purkinje cells. Expressed in cortical neurons and coronary artery
CC       smooth muscle cells (at protein level). Expressed ubiquitously in the
CC       brain. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10801446,
CC       ECO:0000269|PubMed:10873669, ECO:0000269|PubMed:12391161}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the brain (at protein level).
CC       {ECO:0000269|PubMed:10801446}.
CC   -!- DOMAIN: The Ras-associating domain is necessary for the Rap guanine
CC       nucleotide exchange activity. The N-terminal regionis necessary for
CC       cAMP-binding. The PDZ domain is necessary for its targeting to the cell
CC       membrane (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by NEDD4, leading to proteasomal degradation.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation by PLK2 promotes its activity.
CC       {ECO:0000269|PubMed:21382555}.
CC   -!- SIMILARITY: Belongs to the RAPGEF2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EDM00875.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH473976; EDM00875.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; NP_001101154.1; NM_001107684.1.
DR   RefSeq; XP_006232574.1; XM_006232512.3.
DR   AlphaFoldDB; F1M386; -.
DR   BioGRID; 259649; 3.
DR   CORUM; F1M386; -.
DR   IntAct; F1M386; 1.
DR   MINT; F1M386; -.
DR   STRING; 10116.ENSRNOP00000068918; -.
DR   GlyGen; F1M386; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; F1M386; -.
DR   PhosphoSitePlus; F1M386; -.
DR   PaxDb; 10116-ENSRNOP00000037119; -.
DR   Ensembl; ENSRNOT00055002294; ENSRNOP00055001764; ENSRNOG00055001378.
DR   Ensembl; ENSRNOT00065054234; ENSRNOP00065044622; ENSRNOG00065031294.
DR   GeneID; 310533; -.
DR   KEGG; rno:310533; -.
DR   UCSC; RGD:1306434; rat.
DR   AGR; RGD:1306434; -.
DR   CTD; 9693; -.
DR   RGD; 1306434; Rapgef2.
DR   eggNOG; KOG3542; Eukaryota.
DR   HOGENOM; CLU_002782_0_1_1; -.
DR   InParanoid; F1M386; -.
DR   OrthoDB; 5473909at2759; -.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   PRO; PR:F1M386; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Proteomes; UP000234681; Chromosome 2.
DR   Bgee; ENSRNOG00000021581; Expressed in Ammon's horn and 19 other cell types or tissues.
DR   ExpressionAtlas; F1M386; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0005923; C:bicellular tight junction; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030139; C:endocytic vesicle; ISO:RGD.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0031697; F:beta-1 adrenergic receptor binding; ISS:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; ISS:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:RGD.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:UniProtKB.
DR   GO; GO:0070300; F:phosphatidic acid binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0050699; F:WW domain binding; ISS:UniProtKB.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0001568; P:blood vessel development; ISS:UniProtKB.
DR   GO; GO:0031547; P:brain-derived neurotrophic factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; ISS:UniProtKB.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; ISS:UniProtKB.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; ISO:RGD.
DR   GO; GO:0021884; P:forebrain neuron development; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030033; P:microvillus assembly; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048022; P:negative regulation of melanin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0038180; P:nerve growth factor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; ISS:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISS:UniProtKB.
DR   GO; GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; ISS:UniProtKB.
DR   GO; GO:2000670; P:positive regulation of dendritic cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:2001224; P:positive regulation of neuron migration; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0032092; P:positive regulation of protein binding; ISS:UniProtKB.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB.
DR   GO; GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0032486; P:Rap protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; IBA:GO_Central.
DR   GO; GO:1901888; P:regulation of cell junction assembly; ISS:UniProtKB.
DR   GO; GO:0099159; P:regulation of modification of postsynaptic structure; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IDA:UniProtKB.
DR   GO; GO:0021591; P:ventricular system development; ISS:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   CDD; cd01785; RA_PDZ-GEF1; 1.
DR   CDD; cd00155; RasGEF; 1.
DR   CDD; cd06224; REM; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 2.60.120.10; Jelly Rolls; 1.
DR   Gene3D; 1.10.840.10; Ras guanine-nucleotide exchange factors catalytic domain; 1.
DR   Gene3D; 1.20.870.10; Son of sevenless (SoS) protein Chain: S domain 1; 1.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR018490; cNMP-bd_dom_sf.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR45161; CYTOSKELETON-ASSOCIATED PROTEIN 4; 1.
DR   PANTHER; PTHR45161:SF2; RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00314; RA; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 1.
DR   SUPFAM; SSF51206; cAMP-binding domain-like; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   SUPFAM; SSF48366; Ras GEF; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cytoplasm; Developmental protein;
KW   Differentiation; Endosome; GTPase activation;
KW   Guanine-nucleotide releasing factor; Membrane; Neurogenesis;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..1496
FT                   /note="Rap guanine nucleotide exchange factor 2"
FT                   /id="PRO_0000414717"
FT   DOMAIN          267..380
FT                   /note="N-terminal Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00135"
FT   DOMAIN          385..470
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          606..692
FT                   /note="Ras-associating"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00166"
FT   DOMAIN          717..944
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00168"
FT   REGION          40..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          68..101
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1003..1052
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1093..1127
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1139..1159
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1224..1256
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1304..1369
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1390..1496
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        81..96
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1105..1127
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1304..1335
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1338..1352
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         135..252
FT                   /ligand="a nucleoside 3',5'-cyclic phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58464"
FT   MOD_RES         501
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         644
FT                   /note="Phosphothreonine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         806
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         930
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         933
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         1022
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         1079
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4G8"
FT   MOD_RES         1088
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4G8"
FT   MOD_RES         1094
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4G8"
FT   MOD_RES         1115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CHG7"
FT   MOD_RES         1158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4G8"
FT   MOD_RES         1175
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         644
FT                   /note="T->A: Blocks the gel mobility shift induced by PLK2
FT                   and affects stimulation by PLK2; when associated with A-
FT                   806; A-933; A-1022 and A-1175."
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         806
FT                   /note="S->A: Blocks the gel mobility shift induced by PLK2
FT                   and affects stimulation by PLK2; when associated with A-
FT                   644: A-933; A-1022 and A-1175."
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         933
FT                   /note="S->A: Blocks the gel mobility shift induced by PLK2
FT                   and affects stimulation by PLK2; when associated with A-
FT                   644; A-806; A-1022 and A-1175."
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         1022
FT                   /note="S->A: Blocks the gel mobility shift induced by PLK2
FT                   and affects stimulation by PLK2; when associated with A-
FT                   644; A-806; A-933 and A-1175."
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         1175
FT                   /note="S->A: Blocks the gel mobility shift induced by PLK2
FT                   and affects stimulation by PLK2; when associated with A-
FT                   644; A-806; A-933 and A-1022."
FT                   /evidence="ECO:0000269|PubMed:21382555"
SQ   SEQUENCE   1496 AA;  166388 MW;  1F0799FC63293A75 CRC64;
     MKPLAAPANH GVLGQQEKQS LPADFTKLHL TDSLHPQVTH VSSSHSGCSI TSDSGSSSLS
     DIYQATESEA GDMDLSGLPE TAVDSEDDDD EEDIERASDP LMSRDIVRDC LEKDPIDRTD
     DDIEQLLEFM HQLPAFANMT MSVRRELCAV MVFAVVERAG TIVLNDGEEL DSWSVILNGS
     VEVTYPDGKA EILCMGNSFG VSPTMDKEYM KGVMRTKVDD CQFVCIAQQD YCRILNQVEK
     NMQKVEEEGE IVMVKEHREL DRTGTRKGHI VIKGTSERLT MHLVEEHSVV DPTFIEDFLL
     TYRTFLSSPM EVGKKLLEWF NDPSLRDKVT RVVLLWVNNH FNDFEGDPAM TRFLEEFENN
     LEREKMGGHL RLLNIACAAK AKRRSMTLTK PSREAPLPFI LLGGSEKGFG IFVDSVDSSS
     KATEAGLKRG DQILEVNGQN FENIQLSKAM EILRNNTHLS ITVKTNLFVF KELLTRLSEE
     KRNGAPHLPK IGDIKKASRY SIPDLAVDVE QVIGLEKVNK KSKANTVGGR NKLKKILDKT
     RISILPQKPY NDIGIGQSQD DSIVGLRQTK HIPAALPVSG TLSSSNPDLL QSHHRILDFS
     TTPDLPDQVL RVFKADQQSR YIMISKDTTA KEVVIQAIRE FAVTATPEQY SLCEVSVTPE
     GVIKQRRLPD QLSKLADRIQ LSGRYYLKNN METETLCSDE DAQELLRESQ ISLLQLSTVE
     VATQLSMRNF ELFRNIEPTE YIDDLFKLKS KTSCANLKKF EEVINQETFW VASEILRETN
     QLKRMKIIKH FIKIALHCRE CKNFNSMFAI ISGLNLAPVA RLRTTWEKLP NKYEKLFQDL
     QDLFDPSRNM AKYRNVLSGQ NLQPPVIPLF PVIKKDLTFL HEGNDSKVDG LVNFEKLRMI
     AKEIRHVGRM ASVNMDPALM FRTRKKKWRS LGSLSQGSAN ATVLDVAQTG GHKKRVRRSS
     FLNAKKLYED AQMARKVKQY LSNLELEMDE ESLQTLSLQC EPATSTLPKN PADRKPVKSE
     TSPVAPRAGP QQKAQPQQPL APPQPSHKVS QGLQVPAVSL YPSRKKVPVK DLPPFGINSP
     QALKKILSLS EEGSLERHRK QAEDTISNAS SQLSSPPTSP QSSPRKGYAL ALSGTVDNFS
     DSGHSEISSR SSIVSNSSFD SVPVSLHDER RQRHSVSIVE SNLGVGRMER RTLMEPDQYS
     LGSYAPVSES RGLYAAATVI SSPSTEELSH DQGDRASLDA ADSGRGSWTS CSSGSHDNIQ
     TIQHQRSWET LPFGHTHFDY SGDATGIWAS GGHMDQIMFS DHSTKYNRQN QSRESLEQAQ
     SRASWASSTG YWGEDSEGDT GTIKRRGGKD VSTEAESSSM VPVTTEEAKP VPMPAHIAVT
     PSTTKGLIAR KEGRYREPPP TPPGYVGIPI ADFPEGPCHP ARKPPDYNVA LQRSRMVARP
     TEAPAPGQTP PAATASRPGS KPQWHKPSDA DPRLAPFQPQ GFAGAEEDED EQVSAV
//
